tiprankstipranks
Aspire Biopharma Holdings (ASBP)
NASDAQ:ASBP
US Market
ASBP
Aspire Biopharma Holdings
RESEARCH TOOLSreports

Aspire Biopharma Holdings (ASBP) Income Statement

168 Followers

Aspire Biopharma Holdings Income Statement

Last quarter (Q4 2025), Aspire Biopharma Holdings's total revenue was $4.26K, an increase of Infinity% from the same quarter last year. In Q4, Aspire Biopharma Holdings's net income was $-4.71M. See Aspire Biopharma Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 6.20K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -116.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 19.35M$ 3.09M$ 1.34M$ 976.35K$ 25.48K
Depreciation and Amortization
$ 0.00$ 0.00$ 1.34M$ 0.00$ 27.79K
EBITDA
$ -19.35M$ -11.65M$ 5.80M$ 3.34M$ -25.48K
Operating Income
$ -19.35M$ -3.09M$ -1.34M$ -976.35K$ -25.48K
Other Income/Expenses
$ -5.13M$ -9.45M$ 5.80M$ 4.32M$ 5.00
Pretax Income
$ -24.48M$ -12.54M$ 4.46M$ 3.34M$ -25.48K
Net Income
$ -24.48M$ -12.54M$ 4.46M$ 3.34M$ -25.48K
Per Share Metrics
Basic EPS
$ -16.38$ -0.38$ 0.06$ 0.03$ >-0.01
Diluted EPS
$ -16.38$ -0.38$ 0.06$ >-0.01$ >-0.01
Weighted Average Shares Outstanding
 1.49M 32.98M 76.72M 126.74M 25.00M
Weighted Average Shares Outstanding (Diluted)
 1.49M 32.98M 76.72M 126.74M 25.00M
Currency in USD

Aspire Biopharma Holdings Earnings and Revenue History